ES2935818T3 - Formas sólidas de compuestos de 5,6-dihidro-6-fenilbenzo[f]isoquinolin-2-amina sustituidos - Google Patents

Formas sólidas de compuestos de 5,6-dihidro-6-fenilbenzo[f]isoquinolin-2-amina sustituidos Download PDF

Info

Publication number
ES2935818T3
ES2935818T3 ES16876769T ES16876769T ES2935818T3 ES 2935818 T3 ES2935818 T3 ES 2935818T3 ES 16876769 T ES16876769 T ES 16876769T ES 16876769 T ES16876769 T ES 16876769T ES 2935818 T3 ES2935818 T3 ES 2935818T3
Authority
ES
Spain
Prior art keywords
approximately
cancer
compound
water
polymorph
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES16876769T
Other languages
English (en)
Spanish (es)
Inventor
Craig Bates
David P Reed
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arqule Inc
Original Assignee
Arqule Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arqule Inc filed Critical Arqule Inc
Application granted granted Critical
Publication of ES2935818T3 publication Critical patent/ES2935818T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/84—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES16876769T 2015-12-17 2016-12-16 Formas sólidas de compuestos de 5,6-dihidro-6-fenilbenzo[f]isoquinolin-2-amina sustituidos Active ES2935818T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562268747P 2015-12-17 2015-12-17
PCT/US2016/067164 WO2017106642A1 (en) 2015-12-17 2016-12-16 Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds

Publications (1)

Publication Number Publication Date
ES2935818T3 true ES2935818T3 (es) 2023-03-10

Family

ID=59057612

Family Applications (1)

Application Number Title Priority Date Filing Date
ES16876769T Active ES2935818T3 (es) 2015-12-17 2016-12-16 Formas sólidas de compuestos de 5,6-dihidro-6-fenilbenzo[f]isoquinolin-2-amina sustituidos

Country Status (19)

Country Link
US (3) US9981921B2 (enExample)
EP (2) EP3390369B1 (enExample)
JP (2) JP2018537499A (enExample)
KR (1) KR20180086508A (enExample)
CN (1) CN108368061A (enExample)
AU (2) AU2016369523B2 (enExample)
BR (1) BR112018012095A2 (enExample)
CA (1) CA3006081A1 (enExample)
EA (2) EA036295B1 (enExample)
ES (1) ES2935818T3 (enExample)
HK (1) HK1256825A1 (enExample)
IL (1) IL259556B2 (enExample)
MX (2) MX394320B (enExample)
NZ (1) NZ742695A (enExample)
PH (2) PH12018501246A1 (enExample)
SA (1) SA518391805B1 (enExample)
SG (1) SG11201804670PA (enExample)
TW (2) TWI771280B (enExample)
WO (1) WO2017106642A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017106639A1 (en) 2015-12-17 2017-06-22 Arqule, Inc. Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine
TWI771280B (zh) 2015-12-17 2022-07-21 美商亞闊股份有限公司 經取代之5,6-二氫-6-苯基苯并[f]異喹啉-2-胺化合物之固體形式
WO2022053708A1 (en) 2020-09-14 2022-03-17 Basilea Pharmaceutica International AG Pharmaceutical combinations for use in the treatment of gastric adenocarcinoma
JP7641247B2 (ja) 2022-03-02 2025-03-06 日立建機株式会社 機械の性能診断装置

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
WO1998028281A1 (en) 1996-12-23 1998-07-02 Celltech Therapeutics Limited Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors
GB9713087D0 (en) * 1997-06-20 1997-08-27 Celltech Therapeutics Ltd Chemical compounds
EP1638937B1 (en) * 2003-06-18 2008-12-17 Teva Pharmaceutical Industries Limited Fluvastatin sodium crystal form xiv, processes for preparing it, compositions containing it and methods of using it
EP2079736B1 (en) * 2006-12-29 2017-10-18 Rigel Pharmaceuticals, Inc. Substituted triazoles useful as axl inhibitors
MX2011006959A (es) * 2008-12-30 2011-12-06 Arqule Inc Compuestos substituidos de 5,6-dihidro-6-fenilbenzo [f] isoquinolina-2-amina.
KR20130105675A (ko) * 2010-11-25 2013-09-25 라티오팜 게엠베하 아파티닙의 신규 염 및 다형
WO2012177852A1 (en) * 2011-06-24 2012-12-27 Arqule, Inc Substituted imidazopyridinyl compounds
US9802954B2 (en) * 2011-08-24 2017-10-31 Boehringer Ingelheim International Gmbh Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma
EP2760859A1 (en) * 2011-09-30 2014-08-06 Sunshine Lake Pharma Co., Ltd Crystalline forms of azilsartan and preparation and uses thereof
TWI771280B (zh) * 2015-12-17 2022-07-21 美商亞闊股份有限公司 經取代之5,6-二氫-6-苯基苯并[f]異喹啉-2-胺化合物之固體形式
WO2017106639A1 (en) * 2015-12-17 2017-06-22 Arqule, Inc. Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine
US9847831B2 (en) 2016-04-08 2017-12-19 Ciena Corporation Dual wavelenth optical time domain reflectometer systems and methods embedded in a WDM system

Also Published As

Publication number Publication date
PH12018501246A1 (en) 2019-02-04
JP2018537499A (ja) 2018-12-20
EA202091691A1 (ru) 2021-01-29
US10227311B2 (en) 2019-03-12
AU2022201947B2 (en) 2023-07-27
SA518391805B1 (ar) 2022-12-21
WO2017106642A1 (en) 2017-06-22
MX394320B (es) 2025-03-24
TWI771280B (zh) 2022-07-21
HK1256825A1 (zh) 2019-10-04
EP3390369B1 (en) 2022-11-02
EP3390369A4 (en) 2019-08-14
US20200002293A1 (en) 2020-01-02
TWI796250B (zh) 2023-03-11
EA036295B1 (ru) 2020-10-22
US9981921B2 (en) 2018-05-29
PH12020551465A1 (en) 2021-07-26
TW202241854A (zh) 2022-11-01
KR20180086508A (ko) 2018-07-31
US20170174636A1 (en) 2017-06-22
AU2016369523B2 (en) 2021-12-23
EP4019499A1 (en) 2022-06-29
EA201891430A1 (ru) 2018-11-30
US10717710B2 (en) 2020-07-21
NZ742695A (en) 2022-10-28
CN108368061A (zh) 2018-08-03
JP2022031797A (ja) 2022-02-22
AU2016369523A1 (en) 2018-06-07
MX2018007414A (es) 2018-11-09
MX2021000432A (es) 2022-07-28
US20180258055A1 (en) 2018-09-13
BR112018012095A2 (pt) 2018-11-27
AU2022201947A1 (en) 2022-04-14
SG11201804670PA (en) 2018-07-30
CA3006081A1 (en) 2017-06-22
IL259556A (en) 2018-07-31
MX385671B (es) 2025-03-18
IL259556B1 (en) 2023-05-01
EP3390369A1 (en) 2018-10-24
IL259556B2 (en) 2023-09-01
TW201736352A (zh) 2017-10-16

Similar Documents

Publication Publication Date Title
ES2698298T3 (es) Sales de un inhibidor de quinasa receptor de factor de crecimiento epidérmico
CN108658873B (zh) 表皮生长因子受体激酶抑制剂的固体形式
ES2981967T3 (es) Formas polimórficas de RAD1901-2HCl
ES2685819T3 (es) Formas mórficas de ésteres de hexadeciloxipropil-fosfonato
ES2914686T3 (es) Sales de un inhibidor de Pim quinasa
AU2022201947B2 (en) Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds
ES2889476T3 (es) Composiciones y procedimientos relacionados con agonistas 5-HT1F de piridoilpiperidina
ES2908349T3 (es) Sal de derivado de quinazolina o cristal de la misma, y método para producir sal de derivado de quinazolina o cristal de la misma
ES2632548T3 (es) Formas de estado sólido de los inhibidores de la quinasa macrocíclica
ES3039354T3 (en) Solid forms of tetrahydropyranyl amino-pyrrolopyrimidinone compounds
ES2745156T3 (es) Sales y polimorfos de un compuesto imidazopiridinil-aminopiridina sustituido
AU2023256032A1 (en) Crystal of 7h-pyrrolo[2,3-d]pyrimidine-4-amine derivative
JP2024520920A (ja) イミダゾリジノン類化合物の多形体、調製方法及びその使用
HK40079038A (en) Method of preparing solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds
TW202342041A (zh) 一種藥物組合物及所含活性成分化合物的製備方法
HK40072166B (zh) 杂环化合物及其制备方法和用途
BR112018004596B1 (pt) Formas sólidas de um sal, seus usos e métodos de preparo, forma sólida de dosagem oral, método de inibição de pim quinase, composição farmacêutica e método de preparo de um sal
HK1256806B (en) Salts of a pim kinase inhibitor